As of 2026-01-07, the Relative Valuation of Beam Therapeutics Inc (BEAM) is (103.49) USD. This relative valuation is based on P/E multiples. With the latest stock price at 28.93 USD, the upside of Beam Therapeutics Inc based on Relative Valuation is -457.7%.
The range of the Relative Valuation is (92.43) - (101.18) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.1x - 24.8x | 22.5x |
| Forward P/E multiples | 22.6x - 33.8x | 28.2x |
| Fair Price | (92.43) - (101.18) | (103.49) |
| Upside | -419.5% - -449.7% | -457.7% |
| Date | P/E |
| 2026-01-05 | -6.75 |
| 2026-01-02 | -6.64 |
| 2025-12-31 | -6.78 |
| 2025-12-30 | -6.81 |
| 2025-12-29 | -6.81 |
| 2025-12-26 | -6.85 |
| 2025-12-24 | -6.89 |
| 2025-12-23 | -6.80 |
| 2025-12-22 | -6.83 |
| 2025-12-19 | -6.50 |
| 2025-12-18 | -6.40 |
| 2025-12-17 | -6.26 |
| 2025-12-16 | -6.55 |
| 2025-12-15 | -6.57 |
| 2025-12-12 | -6.70 |
| 2025-12-11 | -6.73 |
| 2025-12-10 | -6.71 |
| 2025-12-09 | -6.48 |
| 2025-12-08 | -6.63 |
| 2025-12-05 | -6.63 |
| 2025-12-04 | -7.07 |
| 2025-12-03 | -6.54 |
| 2025-12-02 | -5.72 |
| 2025-12-01 | -5.89 |
| 2025-11-28 | -6.20 |
| 2025-11-26 | -6.13 |
| 2025-11-25 | -6.04 |
| 2025-11-24 | -5.78 |
| 2025-11-21 | -5.44 |
| 2025-11-20 | -5.04 |
| 2025-11-19 | -5.13 |
| 2025-11-18 | -5.36 |
| 2025-11-17 | -5.39 |
| 2025-11-14 | -5.32 |
| 2025-11-13 | -5.30 |
| 2025-11-12 | -5.35 |
| 2025-11-11 | -5.50 |
| 2025-11-10 | -5.30 |
| 2025-11-07 | -5.44 |
| 2025-11-06 | -5.67 |
| 2025-11-05 | -5.65 |
| 2025-11-04 | -5.56 |
| 2025-11-03 | -5.93 |
| 2025-10-31 | -6.12 |
| 2025-10-30 | -5.82 |
| 2025-10-29 | -6.06 |
| 2025-10-28 | -6.47 |
| 2025-10-27 | -6.54 |
| 2025-10-24 | -6.84 |
| 2025-10-23 | -6.90 |